No disparity of the efficacy and all‐cause mortality between Asian and non‐Asian type 2 diabetes patients with sodium–glucose cotransporter 2 inhibitors treatment: A meta‐analysis.

MLA

Cai, Xiaoling, et al. “No Disparity of the Efficacy and All‐cause Mortality between Asian and Non‐Asian Type 2 Diabetes Patients with Sodium–glucose Cotransporter 2 Inhibitors Treatment: A Meta‐analysis.” Journal of Diabetes Investigation, vol. 9, no. 4, July 2018, pp. 850–61. EBSCOhost, https://doi.org/10.1111/jdi.12760.

APA

Cai, X., Gao, X., Yang, W., Chen, Y., Zhang, S., Zhou, L., Han, X., & Ji, L. (2018). No disparity of the efficacy and all‐cause mortality between Asian and non‐Asian type 2 diabetes patients with sodium–glucose cotransporter 2 inhibitors treatment: A meta‐analysis. Journal of Diabetes Investigation, 9(4), 850–861. https://doi.org/10.1111/jdi.12760

Chicago

Cai, Xiaoling, Xueying Gao, Wenjia Yang, Yifei Chen, Simin Zhang, Lingli Zhou, Xueyao Han, and Linong Ji. 2018. “No Disparity of the Efficacy and All‐cause Mortality between Asian and Non‐Asian Type 2 Diabetes Patients with Sodium–glucose Cotransporter 2 Inhibitors Treatment: A Meta‐analysis.” Journal of Diabetes Investigation 9 (4): 850–61. doi:10.1111/jdi.12760.